Revenue
$62.82B
Gross Margin
+70.7%
Operating Margin
+27.6%
Net Margin
+5.8%
Income statement waterfall for AbbVie (ABBV) — TTM through Q1 2026
Net income: $3.64B
Margin breakdown for AbbVie (ABBV) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $62.82B | $62.82B |
| Cost of Revenue | −$18.42B | $44.40B |
| Gross Profit | $44.40B | $44.40B |
| Operating Expenses | −$27.06B | $17.34B |
| Operating Income | $17.34B | $17.34B |
| Other Income / Expense | −$11.37B | $5.97B |
| Pre-tax Income | $5.97B | $5.97B |
| Income Tax | −$2.33B | $3.64B |
| Net Income | $3.64B | $3.64B |
- Revenue$62.82B
- Cost of Revenue−$18.42B
- Gross Profit$44.40B
- Operating Expenses−$27.06B
- Operating Income$17.34B
- Other Income / Expense−$11.37B
- Pre-tax Income$5.97B
- Income Tax−$2.33B
- Net Income$3.64B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement